DTC Ads: Does Repeated Viewing Impact Perceptions About A Drug?
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA plans to study whether frequent viewing of a TV ad effects viewer perception of risks and benefits; costing $1.2 million, it is the sixth DTC ad study to be announced this year.
You may also be interested in...
DTC Advertising For ADHD, Acne, Antidepressant Meds Could Shift After FDA Study
Seeking to better understand how adolescents process information in direct-to-consumer ads, agency proposes survey using web-based promotions for fictitious treatments.
FDA’s Biggest DTC Advertising Study Eyes Online Promotion
The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.